The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Randomized Controlled Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma
Abstract
OBJECTIVE: To clarify the role of splenectomy in total gastrectomy for proximal gastric cancer. BACKGROUNDS: Splenectomy in total gastrectomy is associated with increased operative morbidity and mortality, but its survival benefit is unclear. Previous randomized controlled trials were underpowered and inconclusive. METHODS: We conducted a multiinstitutional randomized controlled trial. Proximal gastric adenocarcinoma of T2-4/N0-2/M0 not invading the greater curvature was eligible. During the operation, surgeons confirmed that R0 resection was possible with negative lavage cytology, and patients were randomly assigned to either splenectomy or spleen preservation. The primary endpoint was overall survival (OS) and the secondary endpoints were relapse-free survival, operative morbidity, operation time, and blood loss. The trial was designed to confirm noninferiority of spleen preservation to splenectomy in OS with a noninferiority margin of the hazard ratio as 1.21 and 1-sided alpha of 5%. RESULTS: Between June 2002 and March 2009, 505 patients (254 splenectomy, 251 spleen preservation) were enrolled from 36 institutions. Splenectomy was associated with higher morbidity and larger blood loss, but the operation time was similar. The 5-year survivals were 75.1% and 76.4% in the splenectomy and spleen preservation groups, respectively. The hazard ratio was 0.88 (90.7%, confidence interval 0.67-1.16) (<1.21); thus, the noninferiority of spleen preservation was confirmed (P = 0.025). CONCLUSIONS: In total gastrectomy for proximal gastric cancer that does not invade the greater curvature, splenectomy should be avoided as it increases operative morbidity without improving survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral Fluoropyrimidine
Sakuramoto, S., Sasako, M., Yamaguchi, T., Kinoshita, T., Fujii, M., Nashimoto, A., Furukawa, H., Nakajima, T., Ohashi, Y., Imamura, H., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072252 · Cited by 2,517
Self-citationDiscrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Japanese Classification of Gastric Carcinoma – 2nd English Edition –
Japanese Gastric Cancer Association (1998) · Gastric Cancer · doi:10.1007/pl00011681 · Cited by 2,170
Japanese gastric cancer treatment guidelines 2010 (ver. 3)
Japanese Gastric Cancer Association (2011) · Gastric Cancer · doi:10.1007/s10120-011-0042-4 · Cited by 2,168
Bonenkamp, J. J., Songun, I., Welvaart, K., van de Velde, C. J. H., Hermans, J., Sasako, M., Plukker, J. T. M., van Elk, P., Obertop, H., Gouma, D. J., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90637-1 · Cited by 1,026
Self-citationD2 Lymphadenectomy Alone or with Para-aortic Nodal Dissection for Gastric Cancer
Sasako, M., Sano, T., Yamamoto, S., Kurokawa, Y., Nashimoto, A., Kurita, A., Hiratsuka, M., Tsujinaka, T., Kinoshita, T., Arai, K., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707035 · Cited by 1,021
Self-citationCuschieri, A., Joypaul, V., Fayers, P. M., Cook, P., Fielding, J. W. L., Craven, J. L., & Bancewicz, J. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90144-0 · Cited by 1,006
Sano, T., Sasako, M., Yamamoto, S., Nashimoto, A., Kurita, A., Hiratsuka, M., Tsujinaka, T., Kinoshita, T., Arai, K., Yamamura, Y., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.184 · Cited by 672
Self-citationSasako, M., Sano, T., Yamamoto, S., Sairenji, M., Arai, K., Kinoshita, T., Nashimoto, A., & Hiratsuka, M. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70766-5 · Cited by 440
Self-citationGastric cancer: ESMO–ESSO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Waddell, T., Verheij, M., Allum, W., Cunningham, D., Cervantes, A., & Arnold, D. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt344 · Cited by 303
Cited by
Japanese gastric cancer treatment guidelines 2014 (ver. 4)
Japanese Gastric Cancer Association (2017) · Gastric Cancer · doi:10.1007/s10120-016-0622-4 · Cited by 2,429
Japanese gastric cancer treatment guidelines 2018 (5th edition)
Japanese Gastric Cancer Association (2021) · Gastric Cancer · doi:10.1007/s10120-020-01042-y · Cited by 1,749
Wang, F., Zhang, X., Li, Y., Tang, L., Qu, X., Ying, J., Zhang, J., Sun, L., Lin, R., Qiu, H., et al. (2021) · Cancer Communications · doi:10.1002/cac2.12193 · Cited by 624
Ajani, J. A., Lee, J., Sano, T., Janjigian, Y. Y., Fan, D., & Song, S. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.36 · Cited by 594
Self-citationCats, A., Jansen, E. P. M., van Grieken, N. C. T., Sikorska, K., Lind, P., Nordsmark, M., Meershoek-Klein Kranenbarg, E., Boot, H., Trip, A. K., Swellengrebel, H. A. M., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30132-3 · Cited by 561
Metadata
- Authors
- Sano, T., Sasako, M., Mizusawa, J., Yamamoto, S., Katai, H., Yoshikawa, T., Nashimoto, A., Ito, S., Kaji, M., Imamura, H., Fukushima, N., & Fujitani, K.
- Venue
- Annals of Surgery
- Published
- 2017-02
- Volume
- 265
- Issue
- 2
- Pages
- 277-283
- ISSN
- 0003-4932 (ISSN-L)
- OpenAlex
- W2416526058
- Cited by
- 323
- References
- 13
- FWCI
- 26.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Randomized Controlled Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma. https://app.cochat.ai/papers/10.1097/sla.0000000000001814
- The paper
- Sano, T., Sasako, M., Mizusawa, J., Yamamoto, S., Katai, H., Yoshikawa, T., Nashimoto, A., Ito, S., Kaji, M., Imamura, H., Fukushima, N., & Fujitani, K. (2017). Randomized Controlled Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma. Annals of Surgery. https://doi.org/10.1097/sla.0000000000001814
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.